Atlas Trials

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis

Clinical trial NCT01109940 · COMPLETED

Trial details

NCT number
NCT01109940
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2010-04-01
Primary completion
2012-12-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.